AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9869578
Drug: Three-point models
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-point models developed for the reference formulation
Trial: 6130195
Drug: Flubendazole 750
RxNorm normalized name: FLUBENDAZOLE
DrugBank: Flubendazole (DB08974)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flubendazole 750 mg intramuscularly once a week for 5 doses
Trial: 6130195
Drug: Diethylcarbamazine (DEC)
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine (DEC) 100 mg twice daily for 14 days
Trial: 29917064
Drug: Peficitinib 25
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Peficitinib 25 mg once daily
Trial: 29917064
Drug: Peficitinib 75
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Peficitinib 75 mg once daily
Trial: 29917064
Drug: Peficitinib 75
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Peficitinib 75 mg twice daily
Trial: 29917064
Drug: Combined peficitinib
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Combined peficitinib group (>=75 mg o.d.)
Trial: 19014841
Drug: Short-course antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course antibiotic therapy (7-14 days)
Trial: 19014841
Drug: Long-course antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-course antibiotic therapy (14-42 days)
Trial: 11812272
Drug: Metered-dose inhaler
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered-dose inhaler (MDI) formulation of ipratropium bromide
Trial: 11812272
Drug: Dry powder
RxNorm normalized name: Dry Powder Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dry powder inhaler (DPI) formulation of ipratropium bromide
Trial: 1897766
Drug: 40 mL
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mL of 0.25% bupivacaine with epinephrine injected intrapleurally postoperatively
Trial: 1897766
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of 0.5% bupivacaine with epinephrine
Trial: 30563273
Drug: two servings
FDA approved: no
EMA approved: no
PMDA approved: no
Description: two servings of protein (77.2 g, 586 kcal)
Trial: 30563273
Drug: two servings
FDA approved: no
EMA approved: no
PMDA approved: no
Description: two servings of carbohydrate (126.8 g, 582 kcal)
Trial: 30563273
Drug: one serving
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: one serving of protein (38.6 g, 293 kcal)
Trial: 30563273
Drug: one serving
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: one serving of carbohydrate (63.4 g, 291 kcal)
Trial: 27797709
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (2 × 28 g/d)
Trial: 27797709
Drug: Calcium caseinate
RxNorm normalized name: calcium caseinate
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium caseinate (2 × 28 g/d)
Trial: 23892826
Drug: Free pharmacotherapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free pharmacotherapy, including nicotine replacement therapy (NRT)
Trial: 23892826
Drug: Nominal incentives,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nominal incentives, e.g., gift cards for groceries
Trial: 23892826
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment or delayed treatment control groups
Trial: 20843217
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of psychosocial skills training, family psycho-education and customary pharmacotherapy
Trial: 20843217
Drug: Customary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Customary treatment alone
Trial: 12811473
Drug: Milk containing
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk containing 1.8 g of non‐esterified pure plant sterols/d
Trial: 10509766
Drug: Uncooked cornstarch
RxNorm normalized name: egg shell, cooked
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uncooked cornstarch (0.46 g available CHO/kg body weight)
Trial: 10509766
Drug: White bread
RxNorm normalized name: White bread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White bread (0.46 g available CHO/kg body weight)
Trial: 1718348
Drug: Preoperative intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Preoperative intra-arterial chemotherapy with vincristine and bleomycin for 12 days
Trial: 1718348
Drug: Preoperative intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Preoperative intra-arterial chemotherapy
Trial: 7039757
Drug: Silicone elastomer
RxNorm normalized name: Dover Foley 3-way Silicone Elastomer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicone elastomer intravenous cannula (Visis)
Trial: 30256751
Drug: HMB/Arg/Gln (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMB/Arg/Gln (1.2 g HMB, 7 g L‐Arg, and 7 g L‐Gln)
Trial: 20959720
Drug: UAG 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UAG 200 μg
Trial: 20959720
Drug: UAG 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UAG 100 μg + AG 100 μg (Comb)
Trial: 11291357
Drug: Paracetamol (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (1000 mg four times a day)
Trial: 9211127
Drug: naloxone (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naloxone (0.8 mg i.v. bolus, followed by infusion of 1.6 mg/h for 120')
Trial: 9211127
Drug: alpha-MSH (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-MSH (2.5 mg i.v. bolus)
Trial: 9211127
Drug: naloxone +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naloxone + alpha-MSH (2.5 mg i.v. 15' after commencement of the naloxone infusion)
Trial: 9211127
Drug: GnRH +
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH + naloxone (100 micrograms i.v. 15' after commencement of the naloxone infusion)
Trial: 9211127
Drug: GnRH +
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH + alpha-MSH (100 micrograms i.v. 15' after commencement of the naloxone infusion)
Trial: 9211127
Drug: placebo (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo (150 nmol/l NaCl solution)
Trial: 7699834
Drug: SY5555 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY5555 at a dose of 5 mg/kg
Trial: 7699834
Drug: SY5555 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY5555 at a dose of 10 mg/kg
Trial: 7699834
Drug: SY5555 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY5555 at a dose of 10 mg/kg (infants)
Trial: 7699834
Drug: SY5555 (comparison
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY5555 (comparison with other antibiotics)
Trial: 2705661
Drug: Subcutaneous immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous immunotherapy with birch pollen allergen preparations, n = 42
Trial: 2705661
Drug: Oral immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunotherapy with birch pollen allergen preparations, n = 14
Trial: 2705661
Drug: Placebo oral
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo oral immunotherapy, n = 16
Trial: 1257366
Drug: Cannabis cigarettes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabis cigarettes delivering 7 mg delta9-THC; administered during four training sessions and tested in the drug condition.
Trial: 1257366
Drug: Non-drug condition;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-drug condition; subjects trained without cannabis.
Trial: 31976814
Drug: Amlodipine (2.5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (2.5-10 mg/day)
Trial: 31976814
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) (12.5-25 mg/day)
Trial: 30659611
Drug: INP104 1.45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: INP104 1.45 mg
Trial: 30659611
Drug: IV DHE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV DHE 1.0 mg
Trial: 30659611
Drug: Migranal 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Migranal 2.0 mg
Trial: 26095948
Drug: Rotigotine (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine (titrated over 1-7 weeks to optimal dose ≤8 mg/24 h for patients not receiving levodopa, ≤16 mg/24 h for patients receiving levodopa)
Trial: 18060659
Drug: Decreased triacylglycerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decreased triacylglycerol (per 1 mmol l(‐1) year(‐1)) in IFG individuals
Trial: 10850898
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (30-minute massage with cocoa butter, twice a week for 5 weeks)
Trial: 6149965
Drug: BW 825C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BW 825C (4 mg)
Trial: 6149965
Drug: BW 825C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BW 825C (8 mg)
Trial: 30738171
Drug: GBR 830
RxNorm normalized name: GBR-12783
DrugBank: GBR-12783 (DB17027)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GBR 830 (10 mg/kg intravenous on day 1 and day 29)
Trial: 24479760
Drug: Tai Chi-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai Chi-based exercise program via telerehabilitation (45-minute session twice a week for eight consecutive weeks)
Trial: 24479760
Drug: Tai Chi-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai Chi-based exercise program provided in person at home (45-minute session twice a week for eight consecutive weeks)
Trial: 8573430
Drug: Tiludronate therapy
RxNorm normalized name: tiludronate
DrugBank: Tiludronic acid (DB01133)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiludronate therapy for 3 years
Trial: 8573430
Drug: Tiludronate therapy
RxNorm normalized name: tiludronate
DrugBank: Tiludronic acid (DB01133)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiludronate therapy for 2 years (non-fracture studies)
Trial: 2092187
Drug: Nimesulide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide (400 mg/die, 2 suppositories per day)
Trial: 2092187
Drug: Flurbiprofen (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen (200 mg/die, 2 suppositories per day)
Trial: 392743
Drug: Myc 2095
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myc 2095 (20 mg)
Trial: 392743
Drug: triamcinolone hexacetonide
RxNorm normalized name: Triamcinolone Hexacetonide
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: triamcinolone hexacetonide (20 mg)
Trial: 31903712
Drug: Exenatide (EXE)
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide (EXE) once weekly (2 mg/wk subcutaneously)
Trial: 25179153
Drug: 500 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 µg nitroglycerin
Trial: 19860883
Drug: 1 ml
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml of triamcinolonacetonide (TCA)
Trial: 14975474
Drug: Combined vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined vitamin E (800 IU per day) and C (1000 mg per day)
Trial: 21255766
Drug: Mental health
RxNorm normalized name: MENS HEALTH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mental health treatment
Trial: 11329998
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for anxiety and depression
Trial: 9221995
Drug: Heparin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin and aspirin
Trial: 8073693
Drug: M‐1 daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M‐1 daily in a dose of 15‐50 g, fish oil in a dose of 10‐30 ml
Trial: 28858279
Drug: Orthodontic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orthodontic treatment with bracket-systems and dental foam (Splat, Russia) after meal (Group 3)
Trial: 28858279
Drug: Orthodontic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orthodontic treatment with bracket-systems (Group 2)
Trial: 28858279
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with no orthodontic treatment (n=35)
Trial: 20725117
Drug: Creatine monohydrate
RxNorm normalized name: Creatine Monohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine monohydrate (25 g.day(‐1) for 5 days, followed by 5 g.day(‐1) for 3 days)
Trial: 18670219
Drug: Albendazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (400 mg daily for 3 days)
Trial: 7861015
Drug: Stavudine (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stavudine (daily doses ranging from 0.1 to 12.0 mg/kg)
Trial: 7861015
Drug: Stavudine (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stavudine (doses of < or = 2 mg/kg/day, n = 216)
Trial: 6894241
Drug: 375 mg
RxNorm normalized name: niacin 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 375 mg azidocillin tablets
Trial: 6894241
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg azidocillin tablets
Trial: 6894241
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg azidocillin tablets
Trial: 6894241
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg azidocillin suspension
Trial: 6894241
Drug: 799 mg
RxNorm normalized name: Mg
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 799 mg azidocillin i.m. injection
Trial: 6894241
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg azidocillin tablets twice daily for 14 days
Trial: 6894241
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg azidocillin i.v. dosage
Trial: 6894241
Drug: i.m. azidocillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. azidocillin dose
Trial: 6894241
Drug: i.v. azidocillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. azidocillin doses
Trial: 6894241
Drug: other dosage
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: other dosage forms of azidocillin
Trial: 6894241
Drug: i.v. administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. administration of azidocillin
Trial: 28811737
Drug: Pedometer-assessed daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pedometer-assessed daily steps
Trial: 28811737
Drug: Accelerometer-assessed minutes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerometer-assessed minutes of daily moderate-to-vigorous PA
Trial: 28811737
Drug: Self-reported minutes
RxNorm normalized name: black imported fire ant allergenic extract
DrugBank: Solenopsis richteri (DB11026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-reported minutes of weekly walking and moderate- and vigorous-intensity PA
Trial: 21211558
Drug: Bitter melon
RxNorm normalized name: BITTER MELON
DrugBank: Momordica charantia fruit (DB14265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bitter melon 2,000 mg/day
Trial: 21211558
Drug: Metformin 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1,000 mg/day
Trial: 21211558
Drug: Bitter melon
RxNorm normalized name: BITTER MELON
DrugBank: Momordica charantia fruit (DB14265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bitter melon 500 mg/day
Trial: 21211558
Drug: Bitter melon
RxNorm normalized name: BITTER MELON
DrugBank: Momordica charantia fruit (DB14265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bitter melon 1,000 mg/day
Trial: 15285981
Drug: Changes in
RxNorm normalized name: guaifenesin / hydrocodone bitartrate Oral Solution [Canges XP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Changes in awareness associated with treatment
Trial: 9397292
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS 30-120 mg/day
Trial: 9397292
Drug: Enalapril 5-30
RxNorm normalized name: enalapril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 5-30 mg/day
Trial: 786807
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no antibiotic cover)
Trial: 30010353
Drug: Tension Tamer
RxNorm normalized name: Ascorbic Acid/Chamomile/Cyanocobalamin/Kava/Magnesium/Pyridoxine/St John's Wort 150 MG-100 MG-0.006 MG-100 MG-25 MG-3 MG-50 MG Oral Capsule [TENSION TAMER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tension Tamer (TT) guided BAM sessions for 5-min intervals twice daily
Trial: 30010353
Drug: Tension Tamer
RxNorm normalized name: Ascorbic Acid/Chamomile/Cyanocobalamin/Kava/Magnesium/Pyridoxine/St John's Wort 150 MG-100 MG-0.006 MG-100 MG-25 MG-3 MG-50 MG Oral Capsule [TENSION TAMER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tension Tamer (TT) guided BAM sessions for 10-min intervals twice daily
Trial: 30010353
Drug: Tension Tamer
RxNorm normalized name: Ascorbic Acid/Chamomile/Cyanocobalamin/Kava/Magnesium/Pyridoxine/St John's Wort 150 MG-100 MG-0.006 MG-100 MG-25 MG-3 MG-50 MG Oral Capsule [TENSION TAMER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tension Tamer (TT) guided BAM sessions for 15-min intervals twice daily
Trial: 28768474
Drug: Progesterone treatment
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone treatment (meta-analysis)
Trial: 20624257
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron (200 mg of iron sucrose) and recombinant human erythropoietin‐β (3000 IU)
Trial: 14714012
Drug: RBC 400
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC 400 mg, clarithromycin 250 mg and metronidazole 500 mg regimen, all drugs given twice daily for 7 days
Trial: 10933004
Drug: Gel materials
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel materials
Trial: 8780106
Drug: Immunosuppressive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppressive treatment (prednisolone plus azathioprine)
Trial: 1344473
Drug: Ranitidine (control)
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine (control) twice daily
Trial: 1344473
Drug: Nizatidine 300
RxNorm normalized name: nizatidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine 300 mg once daily
Trial: 6421560
Drug: Combined regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined regimen of insulin and sulphonylurea (glibenclamide) for ten days, followed by ten days of insulin alone, followed by six months of combined treatment
Trial: 6421560
Drug: Renewed combined
RxNorm normalized name: Renewal
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Renewed combined treatment with sulphonylurea and insulin
Trial: 6421560
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with sulphonylurea and insulin
Trial: 28683243
Drug: 15 grams
RxNorm normalized name: glucose
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 15 grams of protein distributed across 2 isoenergetic carbohydrate-containing beverages (15 and 240 min postexercise) with varying amounts of protein (0 + 15 g, 5 + 10 g, 10 + 5 g, and 15 + 0 g)
Trial: 23932244
Drug: Yoga therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga therapy (60-min sessions weekly for 8 weeks)
Trial: 23932244
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (weekly regular day-care program)
Trial: 15071842
Drug: Nootropil 70
RxNorm normalized name: Other psychostimulants and nootropics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nootropil 70 mg/kg daily
Trial: 15071842
Drug: Nootropil 40
RxNorm normalized name: Other psychostimulants and nootropics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nootropil 40 mg/kg daily
Trial: 11408983
Drug: Topical phenytoin
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical phenytoin sodium
Trial: 27875061
Drug: Glycemic control
RxNorm normalized name: Glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycemic control target of 140 mg/dL
Trial: 27875061
Drug: Glycemic control
RxNorm normalized name: Glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycemic control target of 180 mg/dL